Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1055276-53-3

C39H41N3O4 is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1055276-53-3 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 1055276-53-3 Structure

  • Basic information

    1. Product Name: C39H41N3O4
    2. Synonyms: C39H41N3O4
    3. CAS NO:1055276-53-3
    4. Molecular Formula:
    5. Molecular Weight: 615.772
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 1055276-53-3.mol

  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: N/A
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: C39H41N3O4(CAS DataBase Reference)
    10. NIST Chemistry Reference: C39H41N3O4(1055276-53-3)
    11. EPA Substance Registry System: C39H41N3O4(1055276-53-3)

  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 1055276-53-3(Hazardous Substances Data)

1055276-53-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1055276-53-3 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,5,5,2,7 and 6 respectively; the second part has 2 digits, 5 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 1055276-53:
(9*1)+(8*0)+(7*5)+(6*5)+(5*2)+(4*7)+(3*6)+(2*5)+(1*3)=143
143 % 10 = 3
So 1055276-53-3 is a valid CAS Registry Number.

1055276-53-3Downstream Products

1055276-53-3Relevant articles and documents

Aryl aniline beta2 adrenergic receptor agonists

-

Page 53, (2008/06/13)

The invention provides novel β2 adrenergic receptor agonist compounds of formula (I): wherein R1-R13 and w have any of the values described in the specification. The invention also provides combinations of such compounds and other therapeutic agents, pharmaceutical compositions comprising such compounds and combinations, methods of using such compounds to treat diseases associated with β2 adrenergic receptor activity, and processes and intermediates useful for preparing such compounds.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1055276-53-3